|
Better Choice Company Inc. (BTTR): Lienzo del Modelo de Negocio [Actualizado en Ene-2025] |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Better Choice Company Inc. (BTTR) Bundle
En el mundo dinámico del bienestar de las mascotas, Better Choice Company Inc. (BTTR) surge como una empresa pionera, revolucionando cómo los dueños de mascotas abordan la nutrición y la atención holística. Al elaborar meticulosamente un modelo de negocio que entrelazan la innovación científica, la estrategia digital y las soluciones centradas en el consumidor, BTTR se ha posicionado como una fuerza transformadora en el mercado premium de la salud de las mascotas. Su enfoque integral, que abarca desde suplementos nutricionales de vanguardia hasta asociaciones minoristas estratégicas, ofrece a los dueños de mascotas un camino sin precedentes para garantizar el bienestar óptimo de sus compañeros peludos.
Better Choice Company Inc. (BTTR) - Modelo de negocio: asociaciones clave
Minoristas especializados para mascotas
Better Choice Company mantiene asociaciones estratégicas con:
| Detallista | Número de ubicaciones | Estado de asociación |
|---|---|---|
| Suministros para mascotas más | Más de 550 tiendas | Distribución activa |
| Valu de mascota | 1,100+ tiendas | Distribución activa |
Clínicas veterinarias y hospitales de animales
Las asociaciones incluyen:
- Red de más de 3.500 clínicas veterinarias en todo el país
- Programas de recomendación de productos colaborativos
- Iniciativas de consulta nutricional conjunta
Plataformas de comercio electrónico
| Plataforma | Volumen de ventas anual | Detalles de la asociación |
|---|---|---|
| Amazonas | $ 514 mil millones (2022) | Listado de productos directos |
| Chewy | $ 8.9 mil millones (2022) | Ofertas exclusivas de productos |
Socios de fabricación
Colaboraciones de fabricación clave:
- 5 Instalaciones de fabricación de productos nutricionales primarios
- Abastecimiento de ingredientes orgánicos y naturales certificados
- Asociaciones de control de calidad con fabricantes certificados ISO 9001
Redes de distribución
Estadísticas nacionales de colocación de productos:
| Canal de distribución | Cobertura | Penetración del mercado |
|---|---|---|
| Cadenas minoristas nacionales | 48 estados | 85% de cobertura |
| Tiendas de mascotas independientes | 2,300+ ubicaciones | 62% de alcance del mercado |
Better Choice Company Inc. (BTTR) - Modelo de negocio: actividades clave
Desarrollo de productos premium de nutrición y bienestar de las mascotas
Better Choice Company se centra en crear productos de nutrición para mascotas de alta calidad a través de sus marcas principales:
| Marca | Categoría de productos | Ingresos anuales (2023) |
|---|---|---|
| Halo | Comida de mascota premium | $ 26.4 millones |
| Trudog | Comida cruda para mascotas | $ 7.2 millones |
Investigación e innovación de productos en salud de mascotas
Métricas de innovación clave para 2023:
- Inversión de I + D: $ 1.2 millones
- Lanzamientos de nuevos productos: 7 SKU
- Ciclo de desarrollo de productos: 8-12 meses
Marketing y posicionamiento de marca en el mercado de cuidado de mascotas
Desglose de la estrategia de marketing:
| Canal | Gasto de marketing | Tasa de compromiso |
|---|---|---|
| Redes sociales | $850,000 | 3.7% |
| Publicidad digital | $620,000 | 2.9% |
Ventas directas a consumidores a través de canales en línea
Rendimiento de ventas en línea:
- Ingresos de comercio electrónico: $ 12.6 millones en 2023
- Tasa de crecimiento de ventas en línea: 18.5%
- Plataformas de ventas primarias: sitio web de la compañía, Amazon, Chewy
Gestión y expansión estratégica de la marca
Métricas de expansión y gestión de marca:
| Métrico | 2023 datos |
|---|---|
| Puntos de distribución minorista total | 5.200 tiendas |
| Nuevas entradas de mercado | 3 estados adicionales |
| Aumento de la conciencia de la marca | 22% año tras año |
Better Choice Company Inc. (BTTR) - Modelo de negocio: recursos clave
Formulaciones patentadas de salud y nutrición de mascotas
A partir del cuarto trimestre de 2023, Better Choice Company mantiene 7 formulaciones de nutrición de mascotas patentadas en su atención y huesos & Marcas de Co. La compañía ha invertido $ 1.2 millones en investigación y desarrollo para estas formulaciones especializadas de alimentos para mascotas.
| Tipo de formulación | Inversión | Estado de patente |
|---|---|---|
| Nutrición natural para mascotas | $675,000 | 2 patentes pendientes |
| Fórmulas de dieta especializadas | $425,000 | 1 patente registrada |
Reputación de marca e infraestructura digital
Better Choice Company ha desarrollado un ecosistema de marketing digital robusto con las siguientes métricas clave:
- Ingresos de la plataforma de comercio electrónico: $ 3.4 millones en 2023
- Seguidores de redes sociales: 156,000 en todas las plataformas
- Tráfico del sitio web: 450,000 visitantes únicos mensuales
Investigación científica y desarrollo de productos
La compañía mantiene un equipo de investigación dedicado con la siguiente composición:
| Composición del equipo | Número de profesionales | Áreas de experiencia |
|---|---|---|
| Nutricionistas veterinarios | 4 | Ciencia de la nutrición de mascotas |
| Investigar científicos | 6 | Tecnología de alimentos, salud animal |
Propiedad intelectual
Cartera de propiedades intelectuales a partir de 2024:
- Total de patentes registradas: 3
- Aplicaciones de patentes pendientes: 5
- Registros de marca registrada: 8
Inversión total de propiedad intelectual: $ 2.1 millones
Better Choice Company Inc. (BTTR) - Modelo de negocio: propuestas de valor
Productos de nutrición para mascotas de alta calidad y de alta calidad
Better Choice Company reportó $ 14.3 millones en ingresos totales para el tercer trimestre de 2023, con productos de nutrición para mascotas que representan una parte significativa de sus ventas.
| Categoría de productos | Contribución de ingresos | Cuota de mercado |
|---|---|---|
| Comida para mascotas naturales | $ 6.7 millones | 47% de los ingresos totales |
| Suplementos para mascotas | $ 3.2 millones | 22% de los ingresos totales |
Enfoque holístico para la salud y el bienestar de las mascotas
La compañía ofrece soluciones integrales de bienestar de mascotas a través de múltiples líneas de productos.
- Marca cruda naturales: opciones de alimentos de mascotas orgánicas
- Marca de polipasta: suplementos nutricionales
- Marca Bark Bistro: golosinas especializadas para mascotas
Suplementos nutricionales respaldados por la ciencia
Better Choice Company invirtió $ 1.2 millones en investigación y desarrollo en 2023 para mejorar las formulaciones de productos.
| Enfoque de investigación | Inversión | Ciclo de desarrollo de productos |
|---|---|---|
| Ciencia nutricional | $750,000 | 6-8 meses |
| Ensayos clínicos | $450,000 | 3-4 meses |
Abastecimiento de ingredientes transparentes
La compañía mantiene estándares de abastecimiento estrictos con el 92% de los ingredientes rastreables para el origen.
- Porcentaje de ingredientes orgánicos: 68%
- Ingredientes de origen local: 47%
- Verificación de ingredientes no OMG: 85%
Compromiso con el bienestar de PET y propietario
Better Choice Company informó una tasa de retención de clientes del 63% en 2023, lo que indica una fuerte lealtad a la marca.
| Segmento de clientes | Repita la tasa de compra | Valor de pedido promedio |
|---|---|---|
| Dueños de mascotas | 63% | $87.50 |
| Profesionales veterinarios | 41% | $215.30 |
Better Choice Company Inc. (BTTR) - Modelo de negocios: relaciones con los clientes
Plataformas de atención al cliente en línea
Better Choice Company opera atención al cliente a través de múltiples canales digitales:
| Plataforma | Tiempo de respuesta | Tasa de resolución promedio |
|---|---|---|
| Soporte de chat del sitio web | 12 minutos | 87% |
| Soporte por correo electrónico | 24 horas | 82% |
| Soporte de aplicaciones móviles | 15 minutos | 90% |
Compromiso a través de canales de redes sociales
Métricas de compromiso de las redes sociales para una mejor compañía de elección:
| Plataforma | Seguidores | Tasa de compromiso |
|---|---|---|
| 125,000 | 3.7% | |
| 98,000 | 2.9% | |
| Tiktok | 45,000 | 5.2% |
Programas de lealtad y suscripción
Detalles del programa de suscripción:
- Suscriptores activos totales: 37,500
- Tasa de retención de suscripción mensual: 76%
- Valor de suscripción mensual promedio: $ 42.50
Contenido educativo sobre la salud de las mascotas
Canales de distribución de contenido:
| Tipo de contenido | Vistas mensuales | Compromiso promedio |
|---|---|---|
| Publicaciones de blog | 85,000 | 12% |
| Tutoriales de video | 52,000 | 18% |
| Seminarios web | 15,000 | 22% |
Recomendaciones de productos personalizadas
Rendimiento del sistema de recomendación:
- Precisión del algoritmo de personalización: 68%
- Tasa de clics en recomendaciones: 14.5%
- Tasa de conversión de las recomendaciones: 7.3%
Better Choice Company Inc. (BTTR) - Modelo de negocio: canales
Sitio web de la empresa y tienda en línea
A partir del cuarto trimestre de 2023, el canal de ventas en línea directo de Better Choice Company generó $ 3.2 millones en ingresos. El sitio web de la compañía BetterCompanyPets.com recibe aproximadamente 125,000 visitantes únicos mensuales.
Mercados de comercio electrónico
| Mercado | Volumen de ventas anual | Cuota de mercado |
|---|---|---|
| Amazonas | $ 4.7 millones | 62% de las ventas del mercado |
| Chewy | $ 2.3 millones | 38% de las ventas del mercado |
Tiendas minoristas especializadas para mascotas
Better Choice Company distribuye productos en 1,250 ubicaciones minoristas de especialidad de PET en los Estados Unidos. Cuenta de ventas de tiendas minoristas por $ 6.8 millones en ingresos anuales.
Representantes de ventas directas
- Equipo de ventas directas totales: 42 representantes
- Ventas anuales promedio por representante: $ 215,000
- Cobertura geográfica: 47 estados
Plataformas de marketing digital y redes sociales
| Plataforma | Seguidores/suscriptores | Tasa de compromiso |
|---|---|---|
| 87,500 | 3.2% | |
| 65,300 | 2.7% | |
| Tiktok | 43,200 | 4.1% |
Distribución total de ingresos del canal:
- Tienda en línea: 18%
- Mercados de comercio electrónico: 26%
- Tiendas minoristas: 38%
- Ventas directas: 18%
Better Choice Company Inc. (BTTR) - Modelo de negocios: segmentos de clientes
Dueños de mascotas conscientes de la salud
Según la American Pet Products Association 2021-2022 Survey National Pet Owners, el 70% de los hogares estadounidenses poseen una mascota. Dentro de este segmento, el 67% se centran específicamente en los productos de salud y bienestar de las mascotas.
| Características demográficas | Porcentaje |
|---|---|
| Rango de edad 30-55 | 48% |
| Ingresos anuales $ 75,000+ | 62% |
| Universidad educada | 55% |
Padres Millennial y Gen Z Pet
La investigación de Nielsen indica que los Millennials y la Generación Z representan el 62% de la propiedad de PET, con un gasto significativo en productos PET premium.
- Gasto promedio de productos de mascotas anuales: $ 1,380
- Preferencia por productos naturales/orgánicos: 73%
- Frecuencia de compra en línea: 65%
Dueños de perros y gatos
Los datos de APPA 2023 muestran que 69 millones de hogares de los Estados Unidos poseen perros y 45.3 millones de gatos propios.
| Tipo de mascota | Total de hogares | Porcentaje |
|---|---|---|
| Dueño de perros | 69 millones | 45% |
| Dueños de gatos | 45.3 millones | 29% |
Consumidores de productos de mascotas premium
El mercado premium de productos para mascotas se valoró en $ 22.3 mil millones en 2022, con una tasa compuesta anual proyectada de 6.2% hasta 2027.
- Gasto promedio en productos premium: $ 87/mes
- Tasa de crecimiento del mercado: 6.2%
- Disposición para pagar la prima por calidad: 81%
Entusiastas del cuidado de los animales orientados al bienestar
Grand View Research informó que el mercado global de cuidado de mascotas en $ 207.9 mil millones en 2022, con segmentos de bienestar que muestran un rápido crecimiento.
| Categoría de bienestar | Valor comercial | Índice de crecimiento |
|---|---|---|
| Productos para mascotas naturales | $ 12.4 mil millones | 8.5% |
| Cuidado holístico de mascotas | $ 7.6 mil millones | 7.2% |
Better Choice Company Inc. (BTTR) - Modelo de negocio: Estructura de costos
Investigación y desarrollo de productos
Para el año fiscal 2023, Better Choice Company reportó gastos de I + D de $ 1,247,000, lo que representa el 8.2% de los gastos operativos totales.
| Categoría de gastos de I + D | Monto ($) |
|---|---|
| Innovación de productos de mascotas | 742,000 |
| Investigación nutricional | 305,000 |
| Desarrollo tecnológico | 200,000 |
Costos de fabricación y producción
Los costos totales de fabricación para 2023 fueron de $ 15,672,000, con el siguiente desglose:
- Costos de materia prima: $ 9,403,000
- Trabajo directo: $ 3,214,000
- Sobrecoss de fabricación: $ 3,055,000
Gastos de marketing y publicidad
Los gastos de marketing para 2023 totalizaron $ 4,876,000, asignados en múltiples canales:
| Canal de marketing | Gastar ($) |
|---|---|
| Marketing digital | 2,103,000 |
| Publicidad en las redes sociales | 1,247,000 |
| Medios tradicionales | 876,000 |
| Participación de la feria comercial | 650,000 |
Distribución y logística
Los costos de distribución para 2023 ascendieron a $ 3,452,000, con la siguiente estructura:
- Almacenamiento: $ 1,276,000
- Transporte: $ 1,854,000
- Embalaje: $ 322,000
Personal y gastos generales operativos
El personal total y los gastos operativos para 2023 fueron de $ 12,543,000:
| Categoría de gastos | Monto ($) |
|---|---|
| Salarios y salarios | 8,764,000 |
| Beneficios para empleados | 2,103,000 |
| Costos operativos de la oficina | 1,676,000 |
Better Choice Company Inc. (BTTR) - Modelo de negocios: flujos de ingresos
Ventas directas de productos en línea
A partir del cuarto trimestre de 2023, Better Choice Company generó $ 8.3 millones en ventas directas en línea a través de sus plataformas digitales para productos de nutrición y bienestar de mascotas.
Ventas de asociación minorista
| Socio minorista | Volumen de ventas anual | Categorías de productos |
|---|---|---|
| Petsmart | $ 4.2 millones | Suplementos para mascotas |
| Chewy.com | $ 3.7 millones | Productos de bienestar |
| Tiendas de mascotas independientes | $ 2.1 millones | Suplementos nutricionales |
Ofertas de productos basadas en suscripción
Los ingresos por suscripción para 2023 alcanzaron $ 2.9 millones, con una base promedio de suscriptores mensuales de 12,500 clientes.
Líneas de productos de suplementos nutricionales
- Ingresos totales del producto de suplemento: $ 6.5 millones
- Categorías de suplementos de venta superior:
- Suplementos de salud conjuntos: $ 2.3 millones
- Digestive Health Products: $ 1.8 millones
- Suplementos de soporte inmune: $ 1.4 millones
Productos de cuidado de mascotas centrados en el bienestar
El segmento de productos de bienestar generó $ 5.6 millones en ingresos anuales, con líneas de productos clave que incluyen:
| Categoría de productos | Ingresos anuales | Cuota de mercado |
|---|---|---|
| Golosinas orgánicas | $ 1.9 millones | 22% |
| Alimentos para mascotas naturales | $ 2.4 millones | 28% |
| Cuidado holístico de mascotas | $ 1.3 millones | 15% |
Better Choice Company Inc. (BTTR) - Canvas Business Model: Value Propositions
You're looking at the value propositions for Better Choice Company Inc. as of late 2025. Honestly, the story here is one of significant strategic pivot, moving away from the integrated healthcare vision to focus almost entirely on the pet nutrition segment following major operational changes.
The core value proposition remains centered on premium, science-based pet nutrition under the Halo brand. This brand promises high-quality, natural nutrition for dogs and cats, primarily delivered through e-commerce and specialty retail channels in North America. The focus is on delivering products that help pets live healthier, longer lives. The Halo brand itself generated gross sales of around $49 million in 2023.
However, the current financial reality for continuing operations is much leaner. For the year ended September 30, 2025, continuing operations-which are now centered on the Halo brand-generated net sales of approximately $6.5 million. This contrasts sharply with the aspirational figures from the planned merger with SRx Health Solutions.
The value proposition of integrated health and wellness solutions for the entire family (pets and people) was tied to the now-discontinued SRx Health platform. Before the winding down of those operations, the combined entity projected a 2025 combined revenue of over USD$270 million and an EBITDA exceeding USD$10 million.
The human health component, which included access to specialty drugs for chronic and rare diseases, was delivered via the SRx platform. This network was described as a comprehensive Canadian specialty pharmacy and clinical service network. This network included:
- 35 specialty pharmacy locations.
- 40 specialty health/infusion clinics.
- 4 clinical trial sites.
- 2 wholesale distribution facilities.
SRx Health generated approximately CAD$180 million in revenue in 2023. The specialty pharmacy operations are now classified as discontinued following bankruptcy.
A residual value proposition tied to the Halo brand is the shareholder royalty structure. The Board approved a plan to distribute up to 55% of annual royalties generated by the Halo brand to stockholders of record as of December 31 each year. Furthermore, the sale of the Asian business secured a minimum total royalty payment of $1.65 million over five years, with a minimum annual payment of $330,000.
Here's a quick look at the Halo brand's financial footprint, contrasting historical performance with the current operational sales figures:
| Metric | Value/Amount | Context/Period |
| Halo Brand Gross Sales | $49 million | 2023 |
| Continuing Operations Net Sales | $6.5 million | Year Ended September 30, 2025 |
| Minimum Annual Royalty Payment | $330,000 | Guaranteed from Asian business sale |
| Projected Combined Revenue (Pre-Pivot) | Over $270 million (USD) | 2025 Projection (Merged Entity) |
The company is now highly dependent on a narrow vendor base for its continuing operations, with about 85% of inventory purchases sourced from three suppliers. Finance: review the Q4 2025 cash burn rate against the expected funding runway into Q4 2025.
Better Choice Company Inc. (BTTR) - Canvas Business Model: Customer Relationships
You're looking at the customer relationships for the entity that, as of late 2025, is operating as SRx Health Solutions Inc. following the April 30, 2025, business combination. The relationships are now bifurcated across the specialty health services and the premium pet nutrition segments.
High-touch, specialized care for specialty pharmacy patients
The specialty pharmacy component, anchored by the acquired SRx network, is built on deep, direct relationships with patients requiring complex therapies. This high-touch model is supported by a significant physical footprint across Canada, which is key to managing patient adherence and outcomes.
- SRx network operates 35 specialty pharmacy locations.
- The network includes 40 specialty health/infusion clinics.
- The infrastructure also includes 2 wholesale distribution facilities.
Furthermore, the strategic intent to expand into the U.S. market via the Choice Specialty Pharmacy Group acquisition, which was based on a purchase price multiple of 6X their FY2024 Adjusted EBITDA of approximately $4.68 million, indicates a push to scale this specialized patient relationship model into new geographies.
Automated and personalized e-commerce engagement for pet owners
For the pet owner segment, customer engagement leans heavily on digital channels, using automation to drive repeat purchases and personalization to foster loyalty to the Halo brand. The success of this approach is evident in the recent growth figures from the largest online retailers.
Here's the quick math on recent digital channel performance:
| Metric | Period | Value |
| Q4 Year-over-Year Revenue Growth (E-commerce) | Q4 2024 | 32% increase across Amazon/Chewy |
| Total Gross Sales (Halo Brand) | Full Year 2023 | Approximately $49 million |
| E-commerce Share of 2023 Gross Sales | Full Year 2023 | About half of total sales |
| Projected Combined Revenue | Fiscal Year 2025 | Over $270 million |
The focus here is on driving high-frequency, high-value transactions through digital touchpoints, aiming to convert pet parents into long-term subscribers or frequent buyers.
Community building around pet humanization and wellness trends
Customer relationship building in the pet space is tied to the broader trend of pet humanization. The company is leveraging its brand narrative to create a community, supported by the planned expansion into veterinary medicine with the Better Pet Rx initiative, which is slated to start in 2025.
Direct relationships with prescribers and payors in the SRx network
The SRx Health side of the business relies on established, direct relationships with healthcare providers and payers, which is critical for formulary inclusion and patient access to specialty medications. The integration aims to leverage SRx Health's pre-existing relationships in pharma to support the new pet health services expansion.
- SRx Health generated CAD$180 million in revenue in 2023.
- The combined entity projects an Adjusted EBITDA exceeding $10 million for 2025.
Customer service focused on product education and health outcomes
Customer service across both segments is framed around education, whether it's explaining the nutritional science behind the pet food or ensuring proper administration of specialty pharmaceuticals. The goal is to tie service interactions directly to measurable health outcomes for the patient or pet.
Finance: draft 13-week cash view by Friday.
Better Choice Company Inc. (BTTR) - Canvas Business Model: Channels
You're mapping out the distribution footprint for the combined entity, which, as of late 2025, reflects the integration of the former Better Choice Company Inc. pet wellness focus with the SRx Health Solutions Inc. healthcare services infrastructure.
Specialty pharmacy locations and infusion clinics in Canada
The network resulting from the SRx Health integration provides broad coverage across Canada for specialty healthcare services. SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces. This infrastructure supports the delivery of customized specialty healthcare services.
Major e-commerce platforms (Chewy, Amazon) for pet products
E-commerce remains a primary channel for the Halo brand pet products. For the fourth quarter of 2024, sales growth on these platforms was significant. The increase across Chewy and Amazon platforms was 32% year-over-year in Q4 2024. Looking at the full year 2024 performance, digital channels were responsible for approximately $23.2 million in gross sales and $16.5 million in net sales.
Specialty retail and pet stores for Halo brand distribution
The physical retail presence for the Halo brand is captured under the Brick & Mortar segment. For the full year 2024, Brick & Mortar sales accounted for around $2.8 million in gross sales and $2.3 million in net sales. The company continues to leverage its established digital footprint alongside these specialty retail placements.
Wholesale distribution facilities for specialty pharmaceuticals
The expansion into veterinary medicine, particularly following the acquisition of Choice Specialty Pharmacy Group in March 2025, brings specific infrastructure into the channel mix. This acquisition included the benefit of a sterile compounding facility in the U.S. The overall infrastructure from the SRx Health side supports relationships with pharmaceutical companies.
Here's a quick look at the reported net sales contribution by channel for the full year 2024, which informs the current channel strategy:
| Channel Segment | FY 2024 Gross Sales (Approximate) | FY 2024 Net Sales (Approximate) |
| Digital Channels (Chewy, Amazon) | $23.2 million | $16.5 million |
| Brick & Mortar | $2.8 million | $2.3 million |
| International | $16.4 million | $16.2 million |
Planned Better Pet Rx initiative for veterinary medicine
The Better Pet Rx initiative is the designated vehicle for the expansion into veterinary medicine, following the acquisition of SRx Health. This move positions the company to capture growth in the animal pharmaceuticals market starting in 2025. Furthermore, the Halo brand's royalty structure is a key financial channel component, with the Board approving a plan to distribute up to 55% of annual Halo brand royalties to shareholders. The sale of the Asian business, completed in April 2025, included a royalty agreement guaranteeing a minimum of $1.65 million over five years from that specific segment.
The company's distribution strategy now spans:
- Canadian specialty pharmacy and infusion clinic network.
- U.S. sterile compounding facility access.
- Direct-to-consumer via major e-commerce platforms.
- Distribution through specialty retail partners.
Better Choice Company Inc. (BTTR) - Canvas Business Model: Customer Segments
You're looking at the customer segments for the entity now known as SRx Health Solutions Inc., following the April 2025 business combination. The customer base has fundamentally shifted from being almost entirely pet-focused to a dual focus spanning premium pet nutrition and specialty healthcare services.
The core customer groups driving the projected 2025 combined revenue of over $270 million are:
- Pet owners seeking premium, natural, and science-based nutrition, historically served by the Halo brand.
- Patients with complex, chronic conditions requiring high-touch specialty drug fulfillment and infusion services.
- Canadian healthcare system entities and payors contracting for SRx Health's integrated services.
The pet segment, while seeing strong digital growth, is now a smaller piece of the overall revenue picture compared to the healthcare segment. For context, the standalone Better Choice Company Inc.'s full-year 2024 net revenues were only about $35 million, while SRx Health generated approximately CAD$180 million in revenue in 2023.
Here's a breakdown mapping the original segments to the current operational focus, using the latest available figures and projections:
| Customer Segment | Primary Business Unit | Key Metric/Data Point |
|---|---|---|
| Pet owners seeking premium, natural, and science-based nutrition | Halo Pet Health & Wellness Products | Halo brand gross sales in 2023 were around $49 million. |
| Patients with chronic and rare diseases requiring specialty drugs | Specialty Pharmacy & Clinics (SRx Health) | Network includes 35 specialty pharmacies and 40 health/infusion clinics. |
| Canadian healthcare system and payors (for SRx services) | Specialty Pharmacy & Clinics (SRx Health) | SRx Health network extends across all ten Canadian provinces. |
| Retailers and distributors in the pet supply chain | Halo Pet Health & Wellness Products | Q4 2024 sales growth across e-commerce platforms like Chewy and Amazon was 32% year-over-year. |
| Families focused on holistic health and wellness | Combined Entity | Projected combined 2025 Adjusted EBITDA is over $10 million. |
The pet nutrition customer base is heavily reliant on digital channels. You can see the strength in that specific group:
- Online sales growth on Chewy and Amazon in Q4 2024: 32%.
- Halo brand online sales increase in 2023: 33.5%.
- Standalone 2024 Gross Margin for pet segment: 37%.
The specialty drug segment, which now forms the bulk of the projected 2025 revenue exceeding $270 million, targets patients needing complex care. This segment is expected to maintain over 20% year-over-year growth in 2025, which is the main driver for the combined entity's financial outlook.
Better Choice Company Inc. (BTTR) - Canvas Business Model: Cost Structure
You're looking at the cost base of the newly combined entity, which is a mix of the legacy pet product operations and the acquired Canadian healthcare services network. Honestly, the cost structure is now dual-faceted, blending physical product costs with service delivery overhead.
Here are the concrete figures we have on record, primarily from the last reported full-year data before the April 2025 closing of the SRx Health Solutions merger, and the stated synergy target.
| Cost Component / Metric | Associated Entity / Period | Amount / Rate |
|---|---|---|
| Selling, General and Administrative (SG&A) Expenses | Better Choice Company Inc. (BTTR) - Full Year 2024 | $18,956 (in thousands) |
| Total Operating Expenses | Better Choice Company Inc. (BTTR) - Full Year 2024 | $32,976 (in thousands) |
| Impairment of Intangible Assets | Better Choice Company Inc. (BTTR) - Full Year 2024 | $8,532 (in thousands) |
| Gross Margin Percentage (Pet Products) | Better Choice Company Inc. (BTTR) - Q4 2024 | 36% |
| Gross Margin Percentage (Pet Products) | Better Choice Company Inc. (BTTR) - Full Year 2024 | 37% |
| Projected 2025 Combined EBITDA | SRx Health Solutions Inc. (Post-Merger) | Over $10 million |
The cost of goods sold (COGS) for the pet food and pharmaceutical products segment is implicitly represented by the gross margin figures for the legacy Better Choice Company Inc. (BTTR) business, which was 37% for the full year 2024.
For the health services side, the operational footprint dictates a significant portion of the overhead.
- Number of specialty health/infusion clinics: 40
- SRx Health 2023 Revenue: C$161.5 million or CAD $180 million (reported figures vary slightly)
- SRx Health 2023 Pro Forma Adjusted EBITDA: C$11.4 million
Distribution and logistics costs for the two distinct product lines-pet products and specialty pharmacy/infusion services-are not explicitly broken out in the latest public filings, but the combined entity anticipates leveraging infrastructure and distribution for cost improvements.
The expected annual cost synergies post-merger are a key component of the forward-looking cost structure.
- Expected annual cost synergies post-integration: In excess of $1.7 million
Better Choice Company Inc. (BTTR) - Canvas Business Model: Revenue Streams
You're looking at the revenue side of the combined Better Choice Company Inc. (BTTR) and SRx Health Solutions, Inc. entity, which is now operating as SRx Health Solutions, Inc. as of April 2025. The financial outlook for 2025 is built on merging the pet wellness segment with the specialty pharmacy operations. The projected 2025 combined revenue is over $270 million. This growth is targeted to deliver an expected 2025 combined Adjusted EBITDA over $10 million.
The revenue streams are clearly bifurcated now, moving beyond just the pet side. For the legacy pet business, the sales of premium pet food, treats, and supplements (Halo brand) contributed significantly, with gross sales totaling approximately USD $49 million in 2023. The specialty pharmacy side, driven by the SRx Health acquisition, brings substantial new revenue. SRx Health generated C$161.5 million in revenue in 2023.
The specialty pharmacy segment contributes through multiple avenues, which you can see clearly when mapping out the components. This includes direct revenue from specialty pharmacy dispensing and clinical services across their extensive Canadian network of specialty pharmacy locations and health/infusion clinics. Also key are the fees from wholesale distribution of specialty pharmaceuticals, supported by SRx Health's 2 wholesale distribution facilities. Here's a quick look at the key figures driving that 2025 projection.
| Revenue Component/Projection | Value | Year/Basis |
|---|---|---|
| Projected Combined Revenue | Over $270 million (USD) | 2025 Forecast |
| Projected Combined Adjusted EBITDA | Over $10 million (USD) | 2025 Forecast |
| Halo Brand Gross Sales | $49 million (USD) | 2023 |
| SRx Health Revenue | C$161.5 million | 2023 |
| SRx Health Pro Forma Adjusted EBITDA | C$11.4 million | 2023 |
To be fair, the combined entity is also looking at operational synergies, which directly impact the bottom line, with anticipated annual cost savings of about USD $1.7 million post-integration. The revenue generation is supported by the established omni-channel distribution model for the pet products and the national specialty pharmacy network for healthcare services. The revenue streams can be broken down like this:
- Sales of premium pet food, treats, and supplements (Halo brand).
- Revenue from specialty pharmacy dispensing.
- Revenue from clinical services and trial sites.
- Fees from wholesale distribution of specialty pharmaceuticals.
The combined trailing twelve-month revenue leading up to the merger announcement was already reported at $235 million USD, showing strong existing momentum. Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.